EyePod

John Kitchens, MD, sits down with Diana Do, MD, to discuss the PHOTON results and their relation to patients with diabetic macular edema in clinical practice.

This PER On Air - Ophthalmology Times podcast examines the new treatment paradigm for patients with geographic atropy, following the introduction of complement-targeting therapies. In this podcast, experts, Dr Cecelia Koetting and Dr Talia Kaden review some of the key highlights from the live satellite symposium, Community Practice Connection™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention presented at the 2024 EnVision Summit in Ophthalmology.

In this PER On Air Ophthalmology Times podcast, a team of experts provides insights into the diagnosis and management of patients with NK (including assessing their underlying cause of NK), with a look at the range of treatments available for patients with advanced stages of NK.

In this PER On Air Ophthalmology Times Podcast, a panel of experts takes a closer look at newer-generation anti-VEGF agents for the treatment of nAMD and DME, sharing insights into clinical trial and real-world data, patient education, and other important considerations for treatment. Faculty: Roger A. Goldberg, MD, MBA Vitreoretinal Specialist Bay Area Retina Associates Volunteer Faculty California Pacific Medical Center Walnut Creek, CA David R.P. Almeida, MD, PhD, MBA President and CEO Erie Retina Research Center for Advanced Surgical Exploration Erie, PA Jennifer I. Lim, MD, FARVO Marion H. Schenk Esq. Chair in Ophthalmology for Research of the Aging Eye UIC Distinguished Professor of Ophthalmology Director, Retina Service Vice-Chair, Diversity and Inclusion University of Illinois at Chicago Chicago, IL

In this Ophthalmology Times EyePod podcast, Mandeep S. Singh, MD, PhD, speaks with Mark S. Humayun, MD, PhD, to learn about the progress in developing a stem cell patch for treating advanced dry age-related macular degeneration. Developed by a team of researchers at USC, the stem cell patch represents a significant advancement in treatment. Dr. Humayun talks about the inspiration behind the patch, how his expertise in both ophthalmology and biomedical engineering has been crucial, and insights gained from a Phase 1/2a study. Dr. Humayun also outlines the upcoming steps for a multisite Phase 2b clinical trial and envisions the potential future role of the stem cell patch in the treatment of geographic atrophy.

This podcast features engaging commentary from experts in the clinical management of glaucoma. These experts share information about traditional and newer therapies for glaucoma, including topical drops, sustained drug delivery options, and minimally invasive glaucoma surgery. They discuss safety and efficacy data with an emphasis on appropriate patient selection, as well as key take-home points and practice pearls. Chair: Inas Aboobakar, MD Physician and Surgeon Massachusetts Eye and Ear Instructor in Ophthalmology Harvard Medical School Boston, MA Faculty: Janelle Davison, OD Owner and CEO Brilliant Eyes Vision Center Owner and Clinical Director Premier Dry Eye Spa & Cosmetic Eyecare Marietta, GA Eydie G. Miller-Ellis, MD Professor of Clinical Ophthalmology Perelman School of Medicine at the University of Pennsylvania Director, Glaucoma Service Vice Chair for Faculty Affairs Scheie Eye Institute Perelman Philadelphia, PA

The role of calendars may be growing more important when managing patients with nAMD and DME. How many weeks can patients go between injections with newer anti-VEGF agents versus older options? How short of an injection interval can patients tolerate before it becomes too much of a burden? In this podcast, Murtaza Adam, MD; Laxmi Devisetty, MD, Hong-Uyen Hua, MD; and Sherrol Reynolds, OD; share insights into determining appropriate treatment regimens with these therapies and supporting patient adherence.

Claris CEO, Clarke Atwell, gives an update on the company and their path toward developing treatment for neurotrophic keratitis

Tune in to the first of a new series of Ophthalmology Times EyePod podcasts focusing on innovation in ophthalmology. Throughout this series, we'll be hearing insights from various stakeholders including those in clinical practice, academia, and industry. The overarching message in this podcast is intended to be informational and not promotional. Today, our host Ehsan Sadri, MD, will be in conversation with Jeffry Weinhuff, who is managing partner of Visionary Ventures. And just a quick note: the thoughts and opinions expressed are those of the speakers and do not necessarily represent the opinions of this publication.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of December 17, 2023.

In this episode of EyePod, David Hutton sits down with Neena Haider, PhD, and Arun Upadhyay, PhD, to talk about modifier gene therapy.

Take a look at a review of the highlights from Ophthalmology Times during the week of January 21, 2024.

Take a look at a review of the highlights from Ophthalmology Times during the week of January 7, 2024.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of December 17, 2023.

Explore the practical side of femtosecond laser-assisted cataract surgery (FLACS) with Neda Shamie, MD, and Peter J. McDonnell, MD. In this podcast, they discuss real-world experiences, patient choices, and the nuances of integrating FLACS into practice, offering insights into the latest developments in ophthalmology.

In this episode, Neda Shamie, MD, and Peter J. McDonnell, MD, discuss the benefits and challenges of implementing the many options from the premium lens pipeline into practice, emphasizing the importance of customization based on patients' lifestyles and expectations, while also addressing concerns and sharing their positive experiences with the evolving technology in the field.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of December 2, 2023.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of November 12, 2023.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of November 12, 2023.

Peter J. McDonnell, MD, and Neda Shamie, MD, consider the transformative landscape of cataract surgery, highlighting the impact of small-aperture IOL technology. The conversation delves into its potential benefits, influence on the market, and the evolving role of cataract surgeons in guiding patients through advanced options.

Welcome to this special edition of the Ophthalmology Times® EyePod recorded in conjunction with Physicians’ Education Resource. This podcast features an international panel of ophthalmologists, including Arshad M. Khanani, MD, MA, FASRS; Carl J. Danzig, MD, FASRS; and Anat Loewenstein, MD, MHA, who will discuss unmet needs in the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) — and opportunities for extended treatment intervals that newer agents might provide. This program is designed to help clinicians better appreciate limitations of traditional anti-VEGF agents and optimize the growing toolkit of available therapies.

Welcome to this special edition of the Ophthalmology Times® EyePod recorded in conjunction with Physicians’ Education Resource. This podcast examines how key therapies for treating diabetic macular edema—anti-VEGF agents and corticosteroids—address the underlying pathophysiology of the condition to effectively and safely treat it. In this podcast, 3 ophthalmologists—Fernando Arevalo, MD; Peter Kaiser, MD; and Nathan Steinle, MD—share their insights to help you optimize care for your patients with this common diabetes-related eye disease.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of October 1, 2023.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of September 24, 2023.

In this EyePod® episode, David Hutton sits down with Shankar Musunuru, CEO of Ocugen to discuss updated data for OCU400.

Peter J. McDonnell, MD, and Neda Shamie, MD, discuss the transformative impact of minimally invasive glaucoma surgery (MIGS) on glaucoma care and its integration with cataract surgery, sharing insights and practical tips for ophthalmologists.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of September 17, 2023.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of September 10, 2023.

Bill B. Trattler, MD, Crystal Brimer, OD, Cynthia Matossian, MD, FACS, and Kelly K. Nichols, OD, MPH, PhD, discuss dry eye disease and the various approaches clinicians can take to treat the disease in part 4 of the Viewpoints Podcast.

Bill B. Trattler, MD, Crystal Brimer, OD, Cynthia Matossian, MD, FACS, and Kelly K. Nichols, OD, MPH, PhD, discuss dry eye disease and the various approaches clinicians can take to treat the disease in part 3 of the Viewpoints Podcast.

Bill B. Trattler, MD, Crystal Brimer, OD, Cynthia Matossian, MD, FACS, and Kelly K. Nichols, OD, MPH, PhD, discuss dry eye disease and the various approaches clinicians can take to treat the disease in part 2 of the Viewpoints Podcast.

In this podcast, Bill B. Trattler, MD, Crystal Brimer, OD, Cynthia Matossian, MD, FACS, and Kelly K. Nichols, OD, MPH, PhD, discuss dry eye disease and the various approaches clinicians can take to treat the disease.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of September 3, 2023.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of August 27, 2023.

In this episode, Ophthalmology Times' co-chief medical editors Peter J. McDonnell, MD, and Neda Shamie, MD, delve into the clinical nuances of Demodex blepharitis. Through personal anecdotes, they stress its underrecognized gravity and discuss diagnostic cues like collarettes. The experts share their enthusiasm for improved treatments, echoing the transformative impact seen in dry eye care.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of August 20, 2023.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of August 13, 2023.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of August 6, 2023.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of July 30, 2023.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of July 16, 2023.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of July 9, 2023.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. Take a look at a review of the highlights from Ophthalmology Times during the week of July 2, 2023.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. In the sport, which is a hybrid of badminton, ping-pong and tennis, players use a plastic-perforated ball, slightly heavier than a whiffle ball, and wooden or composite paddles that are about twice the size of ping-pong paddles, with a high potential for eye injuries.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform. A new study found an approach that identifies high-risk patients so all preemies don’t need to undergo an invasive eye exam.

William B. Trattler, MD, highlights some of the novel therapies for dry eye that have recently been approved by the FDA, along with various treatment approaches that are in development.

David Hutton from Ophthalmology Times and Jay Duker talk about wet AMD and the burdens of treatment on patients thanks to the consistent need for follow-ups and more.

Eyenuk Inc. founder and CEO Kaushal Solanki, PhD, went from working for the Defense Department to founding a company with a focus on artificial intelligence for ophthalmology. Find out what led him to make that jump.

Ehsan Sadri, MD, FACS, and William Trattler, MD, highlight some of the pending FDA approvals and PDUFA dates in the anterior segment sector and what these products will mean for ophthalmologists and their patients.

Dr. Jai Parekh, a clinical associate professor of Ophthalmology/The New York Eye & Infirmary of the Mount Sinai School of Medicine and David Hutton, Managing Editor of Ophthalmology Times discuss the importance of ocular health prior to cataract and refractive surgery, specifically with osmolarity testing.

On this part two episode with Colin Carr, founder and CEO of CARR, we hear more about commercial real estate dos and don'ts when managing the space of your practice. Tune in now for the discussion with Ophthalmology Times® executive editor, David Hutton.